Evid Invest

Earnings calendar/AMJB

Alerian MLP Index ETN (AMJB)

Alerian MLP Index ETN (AMJB) Q2 FY2026 (quarter ended ), quarterly report filed : revenue $47.8B, net income $21.2B, diluted EPS -$606.35. Trailing four filed quarters ( to ): revenue $301.7B, diluted EPS $988.32. Figures as reported, in USD.

Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.

Latest filed quarter

The most recent quarter Alerian MLP Index ETN has filed, from EvidInvest's standardized statements.

Period end

Jun 30, 2026

Q2 FY2026

Filed

Aug 6, 2026

Filing date on record

EPS (diluted)

$-606.35

No estimate on record

Revenue

$47.81B

As filed

Net income

$21.16B

As filed

EPS YoY

-213.0%

vs quarter ended 2025-06-30

Revenue YoY

+171.5%

vs quarter ended 2025-06-30

Next report

Jan 14, 2027

Third-party calendar date, not confirmed by a company filing

Run-rate

Trailing twelve months, summed from the last four filed quarters.

TTM EPS (diluted)

$988.32

2025-09-30 through 2026-06-30

TTM revenue

$301.67B

2025-09-30 through 2026-06-30

Filed quarters

7

On record here

Next revenue estimate

—

No estimate on record

Filed quarters

One row per filed statement, newest first

Period endFiledEPS dilutedRevenueEPS YoYRevenue YoY
2026-06-30Q2 FY20262026-08-06$-606.35$47.81B-213.0%+171.5%
2026-03-31Q1 FY20262026-05-01$606.35$49.84B+17.0%+10.0%
2025-12-31Q4 FY20252026-02-13$468.27$180.42B+10306.0%+323.0%
2025-09-30Q3 FY20252025-11-04$520.05$23.60B+11456.7%-44.7%
2025-06-30Q2 FY20252025-08-05$536.46$-66.88B——
2025-03-31Q1 FY20252025-05-01$518.46$45.31B——
2024-09-30Q3 FY20242024-10-30$4.50$42.65B——
EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.